About the Antiviral Group
The ISRV Antiviral Group (ISRV-AVG) was established as a special interest group of ISRV at the time of merger in April 2011 of the former Neuraminidase Inhibitor Susceptibility Network (NISN) with ISRV.
The ISRV Antiviral Group (ISRV-AVG) was established as a special interest group of ISRV at the time of merger in April 2011 of the former Neuraminidase Inhibitor Susceptibility Network (NISN) with ISRV.
The AVG committee co-ordinates the various activities and represent the interests of the ISRV-AVG. Its composition reflects the range of interests and activities of the AVG and is geographically representative of its membership. Committee members have responsibility for organizing particular activities of the group and collating information on subject areas for the website or publication and integrating contributions from the AVG membership.
Members are elected, initially for a period of three years. The procedure and rules for electing new members to the committee are consistent with those adopted for election to the ISRV Council. Additional Members may be co-opted from the general AVG membership to serve on the Executive Committee to ensure a balance of geography, gender, scientific interests and skills.
Members will participate in an Annual Committee Meeting, typically held during an AVG-sponsored meeting. Members also participate in conference calls to generate ideas for AVG meetings/workshops, to advise on publications and other initiatives for scientific exchange, as well as to promote the activities of the Group, and ISRV as a whole.
If you are interested in becoming a member of the Antiviral Special Interest Group, please get in touch.
Contact Us